| Product Code: ETC328900 | Publication Date: Aug 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The UAE Immunology Market encompasses diagnostics, treatments, and research related to the immune system and its disorders. It is a critical component of the healthcare sector, addressing conditions such as autoimmune diseases and immunodeficiency disorders. The market is driven by advancements in medical science and the need for effective immunological therapies.
The UAE Immunology market is experiencing growth due to several factors. Increasing incidence of autoimmune diseases and allergies necessitates immunology-related treatments and medications. Advancements in biotechnology and immunotherapy have led to the development of innovative treatments, fostering market expansion. Additionally, rising healthcare expenditure and government initiatives to improve healthcare infrastructure contribute to the market`s growth.
The UAE Immunology market faces hurdles related to the high cost of advanced immunotherapies and biologics. Balancing affordability with the imperative for cutting-edge treatments poses a complex challenge for healthcare stakeholders. Furthermore, the market contends with evolving disease profiles, necessitating constant adaptation of treatment strategies. Access to specialized immunology care in remote or underserved areas presents an ongoing challenge, requiring innovative solutions for equitable healthcare delivery.
The COVID-19 pandemic had a profound impact on the UAE Immunology market. While the demand for immunology-related treatments remained steady, there was a shift in healthcare priorities towards addressing the immediate crisis. Routine immunology screenings and treatments faced delays and disruptions, leading to concerns about managing chronic conditions. The market also saw fluctuations in the availability of certain immunology drugs due to supply chain challenges. However, the pandemic accelerated the adoption of telemedicine and remote monitoring solutions, which are likely to reshape how immunology care is delivered in the UAE. As the healthcare system adapts and stabilizes, the market is expected to regain momentum.
The UAE Immunology market is crucial for addressing autoimmune diseases and immune system disorders. Leading pharmaceutical companies in this field include AbbVie, Bristol-Myers Squibb, and Roche. They offer a range of biologic and immunosuppressive medications to manage these conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Immunology Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Immunology Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Immunology Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Immunology Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Immunology Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) Immunology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Immunology Market Trends |
6 United Arab Emirates (UAE) Immunology Market, By Types |
6.1 United Arab Emirates (UAE) Immunology Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Drug Class, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Monoclonal Antibody (mAb), 2021-2031F |
6.1.4 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Fusion Proteins, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Immunosuppressants, 2021-2031F |
6.1.6 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Polyclonal Antibody (pAb), 2021-2031F |
6.1.7 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Others, 2021-2031F |
6.2 United Arab Emirates (UAE) Immunology Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Rheumatoid Arthritis, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Psoriatic Arthritis, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Plaque Psoriasis, 2021-2031F |
6.2.5 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Ankylosing Spondylitis, 2021-2031F |
6.2.6 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Inflammatory Bowel Disease, 2021-2031F |
6.2.7 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Prophylaxis of Organ Rejection, 2021-2031F |
6.3 United Arab Emirates (UAE) Immunology Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 United Arab Emirates (UAE) Immunology Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Immunology Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Immunology Market Imports from Major Countries |
8 United Arab Emirates (UAE) Immunology Market Key Performance Indicators |
9 United Arab Emirates (UAE) Immunology Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Immunology Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Immunology Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Immunology Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) Immunology Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Immunology Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Immunology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |